Investing.com - Financial Markets Worldwide

GC Genome Corp (340450)

KOSDAQ
Currency in KRW
8,600.00
-10.00(-0.12%)
Real-time Data·
340450 Scorecard
Full Analysis
Prominent player in the Biotechnology industry
Trading near 52-week Low
Fair Value
Unlock Value
Day's Range
8,570.008,750.00
52 wk Range
8,570.0015,180.00
Key Statistics
Edit
Bid/Ask
8,600.00 / 8,620.00
Prev. Close
8,610
Open
8,650
Day's Range
8,570-8,750
52 wk Range
8,570-15,180
Volume
40.81K
Average Volume (3m)
2.4M
1-Year Change
-
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
340450 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Technical Analysis
Strong Sell
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Unlock All 9
Liquid assets exceed short term obligations
Unlock InvestingPro

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell

GC Genome Corp Company Profile

GC Genome Corporation operates as a clinical genome analysis company in South Korea. It offers hereditary cancer, tissue and liquid biopsy genetic, blood cancer, and homologous recombination deficiency tests under the Green Plan names; Guardant360, a blood genetic profiling test; Guardant Reveal, a liquid biopsy microscopic residual disease detection and recurrence monitoring test; and genetic rare disease testing services for chromosomal microarray, targeted exome sequencing, whole exome sequencing, and diagnostic genome sequencing. The company also provides ai-CANCERCH, an AI algorithm-based multi-cancer early screening test; Jins Sketch, a genetic test for personalized nutrition; Genome Health and Risk Screen that identifies various disease-susceptibility genes; Green Biome for human symbiotic microorganism genetic analysis service; Genome Screen, an optimal genetic test for preemptive action; Telorisk, an indicator of biological age; and drug compatibility DNA test. In addition, it offers G-NIPT, a noninvasive fetal chromosomal abnormality screening test; Prenatal CMA, a diagnostic test for fetal chromosomal abnormalities with higher diagnostic value; i-screen for newborn genetic screening; and dd-cfDNA, a single nucleotide polymorphism test of cell-free nucleic acid derived from organ transplant donors. The company was founded in 2013 and is based in Yongin-si, South Korea.

Industry
Healthcare Providers & Services
Sector
Healthcare
0
Market
South Korea

Compare 340450 to Peers and Sector

Metrics to compare
340450
Peers
Sector
Relationship
P/E Ratio
−612.1x11.3x−0.5x
PEG Ratio
-−0.150.00
Price/Book
6.1x1.4x2.6x
Price / LTM Sales
7.6x1.2x3.2x
Upside (Analyst Target)
-11.1%41.6%
Fair Value Upside
Unlock24.0%6.0%Unlock

Earnings

Latest Release
Apr 30, 2025
EPS / Forecast
15.00 / --
Revenue / Forecast
6.81B / --
EPS Revisions
a
a
Unlock
Last 90 days

340450 Income Statement

FAQ

What Stock Exchange Does GC Genome Trade On?

GC Genome is listed and trades on the KOSDAQ stock exchange.

What Is the Stock Symbol for GC Genome?

The stock symbol for GC Genome is "340450."

What Is the GC Genome Market Cap?

As of today, GC Genome market cap is 203.63B.

What Is GC Genome's Earnings Per Share (TTM)?

The GC Genome EPS (TTM) is -17.81.

From a Technical Analysis Perspective, Is 340450 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has GC Genome Stock Split?

GC Genome has split 0 times.

How Many Employees Does GC Genome Have?

GC Genome has 0 employees.

What is the current trading status of GC Genome (340450)?

As of 28 Jul 2025, GC Genome (340450) is trading at a price of 8,600.00, with a previous close of 8,610.00. The stock has fluctuated within a day range of 8,570.00 to 8,750.00, while its 52-week range spans from 8,570.00 to 15,180.00.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.